You have 9 free searches left this month | for more free features.

prednisone

Showing 1 - 25 of 945

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatocellular Carcinoma Trial (Prednisone)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Prednisone
  • (no location specified)
Jun 2, 2023

Acute Heart Failure Trial (Prednisone)

Not yet recruiting
  • Acute Heart Failure
  • Prednisone
  • (no location specified)
Jun 14, 2023

Nephrotic Syndrome in Children Trial (Huaiqihuang granule, Prednisone, Levamisole )

Not yet recruiting
  • Nephrotic Syndrome in Children
  • Huaiqihuang granule
  • +4 more
  • (no location specified)
Mar 6, 2023

In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)

Not yet recruiting
  • In-stent Restenosis
  • Beijing, Beijing, China
    Fuwai Hospital
Oct 15, 2023

Facial Swelling, Tooth Position Anomalies, Tooth, Impacted Trial in Catanzaro (Prednisone, Placebo)

Completed
  • Facial Swelling
  • +4 more
  • Prednisone
  • Placebo
  • Catanzaro, CZ, Italy
    Magna Graecia University of Catanzaro
Apr 23, 2023

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 21, 2022

Vasectomy Reversal Trial in Orem (Prednisone)

Recruiting
  • Vasectomy Reversal
  • Prednisone
  • Orem, Utah
    Cure PD
Jul 19, 2022

Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

Recruiting
  • Lymphoma
  • +4 more
  • Vysis LSI MYC Break Apart Rearrangement Probe Kit
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)

Recruiting
  • Langerhans Cell Histiocytosis of Bone
  • Prednisone
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Oct 15, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate/Niraparib
  • +5 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 9, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Biopsy
  • +8 more
  • (no location specified)
Jun 8, 2023

Healthy, Atopic Dermatitis Trial in Daytona Beach (LY3872386, Prednisone, Placebo)

Not yet recruiting
  • Healthy
  • Atopic Dermatitis
  • Daytona Beach, Florida
    Fortrea Clinical Research Unit
Nov 1, 2023

Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)

Recruiting
  • Immune Thrombocytopenia
  • Prednisone
  • Recombinant Human TPO
  • Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 17, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Gout, Chronic Kidney Disease, Renal Transplantation Trial in Paris (Anakinra 100Mg/0.67Ml Inj Syringe, Prednisone, Placebo of

Recruiting
  • Gout
  • +2 more
  • Anakinra 100Mg/0.67Ml Inj Syringe
  • +3 more
  • Paris, Ile-De-France, France
    Rhumathology department
Aug 22, 2022

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)

Completed
  • Prostate Cancer
  • San Francisco, California
  • +5 more
Aug 9, 2022

Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Abiraterone Acetate
  • Prednisone
  • Houston, Texas
  • +2 more
Oct 7, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Chronic GVHD Trial in Shanghai (SHR0302, Prednisone)

Recruiting
  • Chronic GVHD
  • Shanghai, Shanghai, China
  • +1 more
Aug 4, 2022

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 16, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)

Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

Suspended
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022